Neutral Result With Novel Agent in Diabetic Cardiomyopathy Neutral Result With Novel Agent in Diabetic Cardiomyopathy

The ARISE-HF trial testing aldose reductase inhibition in asymptomatic diabetic cardiomyopathy did not meet its endpoint but hints at a mechanism that might prevent it.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news